Since then, Axl overexpression and signaling has been implicated in several human malignancies, such as colon [13], breast [14], glioma [15], thyroid [16], gastric [17], melanoma [18], lung cancer [19], and in renal cell carcinoma (RCC) [20]. The gene discussed is AXL; the disease is central nervous system cancer.